AU467511B2 - Dilution agent - Google Patents

Dilution agent

Info

Publication number
AU467511B2
AU467511B2 AU61242/73A AU6124273A AU467511B2 AU 467511 B2 AU467511 B2 AU 467511B2 AU 61242/73 A AU61242/73 A AU 61242/73A AU 6124273 A AU6124273 A AU 6124273A AU 467511 B2 AU467511 B2 AU 467511B2
Authority
AU
Australia
Prior art keywords
dilution agent
dilution
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU61242/73A
Other versions
AU6124273A (en
Inventor
Pierre Vandevoorde Jacques
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU6124273A publication Critical patent/AU6124273A/en
Application granted granted Critical
Publication of AU467511B2 publication Critical patent/AU467511B2/en
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/967Standards, controls, materials, e.g. validation studies, buffer systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • Y10S436/813Cancer
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664Blood serum or blood plasma standard or control
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497Preparation composition [e.g., lysing or precipitation, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331Preservative, buffer, anticoagulant or diluent
AU61242/73A 1972-10-13 1973-10-10 Dilution agent Expired AU467511B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US00297565A US3852415A (en) 1972-10-13 1972-10-13 Compositions for use in radioimmunoassay as a substitute for blood plasma extract in determination of carcinoembryonic antigen
USUS297565 1972-10-13

Publications (2)

Publication Number Publication Date
AU6124273A AU6124273A (en) 1975-05-01
AU467511B2 true AU467511B2 (en) 1975-12-04

Family

ID=23146844

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61242/73A Expired AU467511B2 (en) 1972-10-13 1973-10-10 Dilution agent

Country Status (15)

Country Link
US (1) US3852415A (en)
JP (1) JPS5315130B2 (en)
AU (1) AU467511B2 (en)
BE (1) BE805991A (en)
CA (1) CA1012458A (en)
CH (1) CH584409A5 (en)
DD (1) DD108151A5 (en)
DE (1) DE2349738C3 (en)
FR (1) FR2203525A5 (en)
GB (1) GB1423244A (en)
IL (1) IL43378A (en)
IT (1) IT1001584B (en)
NL (1) NL161884C (en)
SE (1) SE417460B (en)
ZA (2) ZA723264B (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3901870A (en) * 1974-03-12 1975-08-26 Behringwerke Ag Derivative of alpha' 1'-fetospecific serum protein and process for its manufacture
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US3999944A (en) * 1975-02-28 1976-12-28 Hoffmann-La Roche Inc. Detection of breast cancer
US4043757A (en) * 1975-05-20 1977-08-23 Ortho Pharmaceutical Corporation Method for detection of human mammary carcinoma
US4152410A (en) * 1975-09-03 1979-05-01 Eisai Co., Ltd. Diagnosis reagent for neoplasm and method for diagnosis of neoplasm
US4379839A (en) * 1977-05-23 1983-04-12 The Trustees Of Columbia University In The City Of New York Method for detecting cancer
JPS562557A (en) * 1979-06-22 1981-01-12 Green Cross Corp:The Aqueous solvent for coagulation test
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
JPS57208459A (en) * 1981-06-19 1982-12-21 Eisai Co Ltd Measuring method using enzyme-labelled antibody and reagent
US4631254A (en) * 1982-12-06 1986-12-23 Hoffmann-La Roche Inc. Carcinoembryonic antigen determination
US4624916A (en) * 1984-04-06 1986-11-25 International Immunoassay Laboratories, Inc. Process and composition for the rapid quantitation of small levels of creative kinase-MB isoenzyme
JPS61280566A (en) * 1984-09-03 1986-12-11 Hiroaki Sawai Direct immunoassay of 2'-5'-oligoadenylic acid
US4690772A (en) * 1985-06-03 1987-09-01 National Medical Care Sterilant compositions
US6013772A (en) * 1986-08-13 2000-01-11 Bayer Corporation Antibody preparations specifically binding to unique determinants of CEA antigens or fragments thereof and use of the antibody preparations in immunoassays
CA1296253C (en) * 1986-10-20 1992-02-25 Praveen Tyle Stabilized growth hormone compositions
US5296377A (en) * 1992-12-15 1994-03-22 Boehringer Mannheim Corporation Control reagent containing a hydroxylamine or an antioxidant
MX349265B (en) 2010-05-20 2017-07-20 Ecolab Usa Inc Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof.
KR102384708B1 (en) * 2020-06-19 2022-04-11 대한민국 Artificial blood for bloodstain pattern analysis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3720760A (en) * 1968-09-06 1973-03-13 Pharmacia Ab Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples
US3697638A (en) * 1970-06-01 1972-10-10 Hoffmann La Roche Antigens

Also Published As

Publication number Publication date
US3852415A (en) 1974-12-03
JPS4971133A (en) 1974-07-10
AU6124273A (en) 1975-05-01
IT1001584B (en) 1976-04-30
NL161884B (en) 1979-10-15
IL43378A0 (en) 1974-01-14
DE2349738A1 (en) 1974-04-18
SE417460B (en) 1981-03-16
NL7314093A (en) 1974-04-16
DE2349738B2 (en) 1978-01-19
ZA723264B (en) 1974-08-28
JPS5315130B2 (en) 1978-05-23
ZA737693B (en) 1974-08-28
BE805991A (en) 1974-04-12
IL43378A (en) 1976-04-30
GB1423244A (en) 1976-02-04
CH584409A5 (en) 1977-01-31
DE2349738C3 (en) 1981-06-19
FR2203525A5 (en) 1974-05-10
CA1012458A (en) 1977-06-21
NL161884C (en) 1980-03-17
DD108151A5 (en) 1974-09-05

Similar Documents

Publication Publication Date Title
AU462348B2 (en) Saf-t-jet
AU467469B2 (en) Trifluoromethylmercaptoacetamindocephalosphorins
AU463917B2 (en) Diagnostic agent
AU467511B2 (en) Dilution agent
AU454372B2 (en) Childsafe actuator-overcap
AU469305B2 (en) Deipenylyl-alkanoylaminopyridine
AU475339B2 (en) S-substituted-2-thiodenosines
AU5969473A (en) Bleaching agent
AU475748B2 (en) Napnthopyrans
CA987995A (en) Sequestering agent
AU470359B2 (en) Sulphamoylphenyl-imidazolidinones
AU468159B2 (en) 5-aroyl-furans
AU466344B2 (en) Cycloalkyllactamimides
CA967876A (en) Sterilizing agent
AU471369B2 (en) Diphenylmethoxyethylamines
CA1003330A (en) Diagnostic agent
AU468236B2 (en) 2-acyl-5-nitrothiazoles
AU473297B2 (en) Indolylimidoylheterocyclics
AU467526B2 (en) Pyronorifamycins
AU468599B2 (en) 15-oxasteroids
AU472554B2 (en) Isothocyanobenzoxazoles
AU467183B2 (en) Antistatic agent
CA902644A (en) Dihalophenyl-bis-(hydroxyarylethers)
CA910295A (en) Antifertility agent
CA898778A (en) Structures